Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: A retrospective cohort study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Koo, Hyang Mo ^a   Doh, Fa Mee ^a   Ko, Kwang Il ^a   Kim, Chan Ho ^a   Lee, Mi Jung ^a   Oh, Hyung Jung ^a   Han, Seung Hyeok ^a   Kim, Beom Seok ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Contrast induced nephropathy; Diastolic dysfunction; E E'

Indexed keywords

C REACTIVE PROTEIN; CREATININE; IODIXANOL;

ADULT; ARTICLE; COMORBIDITY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HUMAN; INTRAAORTIC BALLOON PUMP; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURVIVAL;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, DIASTOLIC; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84880125686     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-146     Document Type: Article

References (43)

1. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Goldfarb S, McCullough PA, McDermott J, Gay SB, Mayo Clin Proc Mayo Clin 2009 84 170 179
2. The clinical and renal consequences of contrast-induced nephropathy. Finn WF, Nephrol, Dial, Transplantat 2006 21 2 10
3. Contrast-induced acute kidney injury. McCullough PA, J Am Coll Cardiol 2008 51 1419 1428
4. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW, Am J Cardiol 2004 93 1515 1519
5. Goldenberg I, Matetzky S, CMAJ: Can Med Assoc J = Journal de l'Association Medicale Canadienne 2005 172 1461 1471
6. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Mehran R, Nikolsky E, Kidney Int Suppl 2006 100 11 15
7. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Rosenstock JL, Gilles E, Geller AB, Panagopoulos G, Mathew S, Malieckal D, DeVita MV, Michelis MF, Int Urol Nephrol 2010 42 1049 1054
8. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, et al. Am J Cardiol 2004 94 300 305
9. Prophylaxis strategies for contrast-induced nephropathy. Pannu N, Wiebe N, Tonelli M, JAMA 2006 295 2765 2779
10. Clinical practice. Preventing nephropathy induced by contrast medium. Barrett BJ, Parfrey PS, New Engl J Med 2006 354 379 386
11. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A, Eur J Echocardiogr 2009 10 165 193
12. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ, Circulation 2000 102 1788 1794
13. Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. Sohn DW, Song JM, Zo JH, Chai IH, Kim HS, Chun HG, Kim HC, J Am Soc Echocardiogr 1999 12 927 931
14. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, et al. J Am Coll Cardiol 2004 44 1393 1399
15. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Crit Care 2007 11 31
16. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 461 470
17. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N, Am J Cardiol 1986 57 450 458
18. Pathophysiology of contrast-induced nephropathy. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA, Am J Cardiol 2006 98 14K 20K
19. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, et al. Am J Cardiol 2005 95 13 19
20. Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Heyman SN, Rosenberger C, Rosen S, Nephrol, Dial, Transplant 2005 20 Suppl 1 6 11
21. Contrast nephropathy after coronary angiography. Gami AS, Garovic VD, Mayo Clin Proc Mayo Clin 2004 79 211 219
22. Diastolic heart failure versus diastolic dysfunction: difference in renal function. Victor BM, Barron JT, Clin Cardiol 2010 33 770 774
23. Progression of preclinical diastolic dysfunction to the development of symptoms. de Sa DD C, Hodge DO, Slusser JP, Redfield MM, Simari RD, Burnett JC, Chen HH, Heart 2010 96 528 532
24. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM, J Am Coll Cardiol 2010 56 845 854
25. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Borlaug BA, Paulus WJ, Eur Heart J 2011 32 670 679
26. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. Phan TT, Abozguia K, Nallur Shivu G, Mahadevan G, Ahmed I, Williams L, Dwivedi G, Patel K, Steendijk P, Ashrafian H, et al. J Am Coll Cardiol 2009 54 402 409
27. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure. Afshinnia F, Spitalewitz S, Chou SY, Gunsburg DZ, Chadow HL, Am J Fidney Dis 2007 49 227 236
28. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Gajarsa JJ, Kloner RA, Heart Fail Rev 2011 16 13 21
29. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL, Hypertension 2010 56 225 231
30. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z, J Biol Chem 2007 282 11221 11229
31. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Hartog JW, Voors AA, Bakker SJ, Smit AJ, Van Veldhuisen DJ, Eur J Heart Fail 2007 9 1146 1155
32. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Basta G, Schmidt AM, De Caterina R, Cardiovasc Res 2004 63 582 592
33. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL, Smit A, Cardiovasc Diabetol 2008 7 29
34. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Kamikawa A, Ishii T, Shimada K, Makondo K, Inanami O, Sakane N, Yoshida T, Saito M, Kimura K, Diabetes Metab Res Rev 2008 24 331 338
35. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Nordquist L, Brown R, Fasching A, Persson P, Palm F, Am J Physiol Renal Physiol 2009 297 1265 1272
36. Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Fiorina P, La Rocca E, Astorri E, Lucignani G, Rossetti C, Fazio F, Giudici D, Di Carlo V, Cristallo M, Pozza G, Secchi A, Diabetes Care 2000 23 1804 1810
37. Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. Perseghin G, Fiorina P, De Cobelli F, Scifo P, Esposito A, Canu T, Danna M, Gremizzi C, Secchi A, Luzi L, Del Maschio A, J Am Coll Cardiol 2005 46 1085 1092
38. Electrocardiographic abnormalities and uremic cardiomyopathy. Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, Stuart R, Rodger C, Jardine AG, Kidney Int 2005 67 217 226
39. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Wang BH, Krum H, Eur Heart J 2010 31 1771 1779
40. Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis. Dickhout JG, Carlisle RE, Austin RC, Circ Res 2011 108 629 642
41. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials. Zhang L, Lu Y, Wu B, Zhang S, Jiang H, Ge J, Chen H, Int J Clin Pract 2011 65 624 630
42. Contrast-induced nephropathy. Gleeson TG, Bulugahapitiya S, AJR Am J Roentgenol 2004 183 1673 1689
43. Impact of renin-angiotensin-aldosterone blockade by angiotensin- converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus- Diuresis (DVD) trial. Kiski D, Stepper W, Brand E, Breithardt G, Reinecke H, Nephrol, Dial, Transplant 2010 25 759 764